Pacific Biosciences of California, Inc. (PACB)
1.28
-0.07
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
1.33
+0.05
(+3.91%)
After-Hours: 20:00
Pacific Biosciences of California EPS Diluted (Quarterly) : -0.144 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.144 |
| March 31, 2026 | -0.0271 |
| December 31, 2025 | -0.1337 |
| September 30, 2025 | -0.1263 |
| June 30, 2025 | -0.1397 |
| March 31, 2025 | -1.435 |
| December 31, 2024 | -0.4745 |
| September 30, 2024 | -0.2225 |
| June 30, 2024 | -0.6363 |
| March 31, 2024 | -0.29 |
| December 31, 2023 | -0.307 |
| September 30, 2023 | -0.2622 |
| June 30, 2023 | -0.2792 |
| March 31, 2023 | -0.3636 |
| December 31, 2022 | -0.373 |
| September 30, 2022 | -0.3419 |
| June 30, 2022 | -0.318 |
| March 31, 2022 | -0.3666 |
| December 31, 2021 | -0.3141 |
| September 30, 2021 | 0.0769 |
| June 30, 2021 | -0.2065 |
| March 31, 2021 | -0.4489 |
| December 31, 2020 | 0.3676 |
| September 30, 2020 | -0.1421 |
| June 30, 2020 | -0.1497 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0081 |
| December 31, 2019 | -0.0006 |
| September 30, 2019 | -0.1904 |
| June 30, 2019 | -0.161 |
| March 31, 2019 | -0.2005 |
| December 31, 2018 | -0.2063 |
| September 30, 2018 | -0.1853 |
| June 30, 2018 | -0.1709 |
| March 31, 2018 | -0.1954 |
| December 31, 2017 | -0.18 |
| September 30, 2017 | -0.19 |
| June 30, 2017 | -0.2623 |
| March 31, 2017 | -0.26 |
| December 31, 2016 | -0.21 |
| September 30, 2016 | -0.19 |
| June 30, 2016 | -0.21 |
| March 31, 2016 | -0.23 |
| December 31, 2015 | -0.02 |
| September 30, 2015 | 0.02 |
| June 30, 2015 | -0.16 |
| March 31, 2015 | -0.27 |
| December 31, 2014 | -0.26 |
| September 30, 2014 | -0.13 |
| June 30, 2014 | -0.27 |
| March 31, 2014 | -0.28 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Illumina, Inc. | 1.353 |
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Danaher Corp. | 1.230 |
| Thermo Fisher Scientific, Inc. | 4.679 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.74M |
| Revenue (Quarterly) | 39.01M |
| Total Expenses (Quarterly) | 83.75M |
| Enterprise Value | 867.06M |
| Gross Profit Margin (Quarterly) | 30.26% |
| Profit Margin (Quarterly) | -114.7% |
| Earnings Yield | -33.68% |
| Normalized Earnings Yield | -30.66 |